EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JUL 2022
TABLES
411
PAGES
657
EDITION
17
PRICE
USD 5600
CODE
MCP-6759
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Molecular Cytogenetics Market to Reach $2.5 Billion by 2026
Molecular Cytogenetics involves all aspects of chromosome biology, such as structural and functional organization of the chromosome and nucleus, chromosomal variation and abnormalities, and the applications of chromosome biology in medicine and tumor genetics. Cytogenetics plays an important role in identification of genetic predisposition to disease and also a person`s reaction to a certain drug. Molecular biology techniques evolved from simple tools such as In situ Hybridization (ISH), which detects the presence, quantity, and location of DNA/RNA sequences in cells and tissues, by using a labeled sequence fragment called a "probe". These screening tests analyze complicated genomic interactions and help to determine the progress of a disease. Increasing incidence of cancer and genetic abnormalities, need for rapid disease diagnosis through genetic techniques, as well as higher funding (both public and private) leading to introduction of highly advanced cytogenetic techniques and their broadening applications are some of the key factors poised to contribute to future growth of the market. Growing awareness levels of genetic disorders and expanding pool of research laboratories specializing in molecular biology techniques, would be beneficial for cytogenetics solutions.
Amid the COVID-19 crisis, the global market for Molecular Cytogenetics estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2026, growing at a CAGR of 7.7% over the analysis period. Consumables, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$1.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $794.6 Million in 2022, While China is Forecast to Reach $159.7 Million by 2026
The Molecular Cytogenetics market in the U.S. is estimated at US$794.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$159.7 Million by the year 2026 trailing a CAGR of 8.9% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.
Growth in these markets is driven by increasing incidence of cancer and genetic abnormalities, need for rapid disease diagnosis through genetic techniques, as well as higher funding (both public and private) leading to introduction of highly advanced cytogenetic techniques and their broadening applications are some of the key factors poised to contribute to future growth. Significant rise in target patient population across the world, and rising preference for CGH in clinical diagnosis, is expected to drive the market further, providing players with lucrative opportunities. Growing awareness levels of genetic disorders and expanding pool of research laboratories specializing in molecular biology techniques, would be beneficial for cytogenetics solutions. Rise in incidence of cancer and the subsequent demand for personalized medicine, is likely to enhance market prospects in a major way.
Software & Services Segment to Reach $451.8 Million by 2026
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 8.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$231.2 Million will reach a projected size of US$404.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$24.1 Million by the year 2026, while Latin America will expand at a 9.2% CAGR through the analysis period.
SELECT PLAYERS
Abbott Molecular; Agilent Technologies, Inc.; Applied Spectral Imaging; Biological Industries; Bio-Rad Laboratories, Inc.; Cytognomix, Inc.; CytoTest, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Leica Biosystems Nussloch GmbH; Oxford Gene Technology; PerkinElmer, Inc.; SciGene Corporation; Thermo Fisher Scientific, Inc.
SEGMENTS
» Component (Consumables, Instruments, Software & Services) » Technique (CGH, FISH, Immunohistochemistry, Karyotyping, Other Techniques) » Application (Genetic Disorders, Cancer, Personalized Medicine, Other Applications) » End-Use (Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of COVID-19 and a Looming Global Recession |
EXHIBIT: COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019E to 2022F |
Challenges and Opportunities for Clinical Diagnostics amid the Pandemic |
French Research Team Develops CoronaFISH |
Immuno RNA Fluorescence ISH for Visualization of COVID-19 Causing SARS-CoV-2 |
Molecular Cytogenetics Technologies: An Introductory Prelude |
Future Prospects Remain Favorable for Cytogenetics Technologies |
Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
EXHIBIT: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023 |
Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities |
Developed Regions: Key Revenue Contributors |
EXHIBIT: Developed Regions Account for Lion's Share of World Molecular Cytogenetics Technologies Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2020E & 2027P) |
Fast Paced Growth Projected in Developing Regions |
EXHIBIT: Global Market for Molecular Cytogenetics Technologies - Geographic Regions Ranked by % CAGR (Revenues) for 2020-2027: China, Asia-Pacific, Latin America, USA, Middle East, Africa, Canada, Europe, and Japan |
Competitive Scenario |
Recent Market Activity |
Molecular Cytogenetics – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth |
Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies |
Comparative Genome Hybridization (CGH): Largest & Fastest Growing Market Segment |
Rising Adoption of Array Based CGH to Spur Overall Demand |
EXHIBIT: Array-based Technologies Continue to Cannibalize Sales from FISH Technology: Percentage (%) Share of Array-Based Solutions in World Cytogenetics Technologies Market (2018 & 2022) |
aCGH Simplifies Diagnosis of Chromosomal Anomalies |
Clinical Pathological Testing: A Growing Vertical for aCGH |
Impact of Rising Emphasis on R&D on Microarray Technology |
Leveraging Established Use Case, FISH Technology Continues to Find Favor |
Next Generation Sequencing Seeks Role in Cytogenetics Processes |
Molecular Cytogenetics Greatly Benefit Cancer Prognosis |
EXHIBIT: Breakdown of Total Number of Cancer Cases by Region: 2020 |
EXHIBIT: Breakdown of Total Number of Cancer Cases by Type: 2020 |
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
Cancer Care Made Easier with Highly-Multiplexed FISH |
Diverse Applications of FISH Technology in Oncology |
Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities |
Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis |
Uptrend in Genetic Disease Testing Augments Prospects |
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence |
Top Ten Genetic Diseases Worldwide |
Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth |
Expanding Role of Molecular Cytogenetics in Personalized Medicine |
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 |
EXHIBIT: World Personalized Medicine Market by Region/Country (2021): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World |
EXHIBIT: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population |
Companion Diagnostics Lead the Way to Personalized Medicine |
Digitalization, Automation and AI Trends Set to Shape Future Growth |
Lab Automation Speeds Up |
EXHIBIT: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026 |
Laboratory 4.0 Set to Transform Molecular Cytogenetics Landscape |
Laboratory Information Systems Gain Traction |
Artificial Intelligence : The Future of LIS |
Biotech Research Spending Patterns Steer Momentum |
Technology Advancements & Improvements Bolster Growth |
Ageing Demographics to Drive Demand |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 |
EXHIBIT: Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050) |
Technology Overview |
A Preface to Cytogenetics |
Basic Terms and Definitions in Molecular Biology |
An Overview of Select Chromosomal Anomalies |
Molecular Cytogenetics |
Insight into Molecular Cytogenetics Techniques |
Fluorescence in situ Hybridization (FISH) |
Comparative Genomic Hybridization (CGH) |
Advent of Microarray Technology |
Microarrays in Comparative Genomic Hybridization |
Principle Underlying aCGH |
Low Resolution and High Resolution aCGH |
A Review of Molecular Biology Techniques in Cytogenetics |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Molecular Cytogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for CGH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for CGH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for CGH by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for FISH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for FISH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for FISH by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Karyotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Karyotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Karyotyping by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Genetic Disorders by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Clinical & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Clinical & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Clinical & Research Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
The United States: Prime Market for Cytogenetics Technologies |
CGH Technologies Witness Higher Adoption |
Established Role Sustains Momentum in FISH Technology |
Ageing Population and Growing Incidence of Cancer & Lifestyle Diseases – Opportunity Indicators |
EXHIBIT: US Elderly Population: Expected Growth Rates Over the Years 2005-2025 |
EXHIBIT: Leading Sites of New Cancer Cases in Males: 2020 |
EXHIBIT: Leading Sites of New Cancer Cases in Females: 2020 |
Emphasis on Personalized Medicine & Companion Diagnostics Widens Scope |
EXHIBIT: US Personalized Medicine Market: Breakdown of Revenues (in US$ Billion) for 2014, 2018 and 2022 |
EXHIBIT: US Companion Diagnostics (CDx) Market: Breakdown of Revenues (in US$ Million) for 2014, 2018 and 2022 |
Growing Focus on Genetic Testing Widens the Business Case |
Emphasis on Early Diagnosis & Need to Reduce Healthcare Costs Augment Demand |
USA Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
CANADA |
An Overview |
Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand |
EXHIBIT: Number of New Cancer Cases in Canada: 2019 |
Canada Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
JAPAN |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Offers Robust Opportunities |
EXHIBIT: Japanese Elderly (65+ Years) Population: 2000-2020 |
EXHIBIT: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025 |
Japan Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
CHINA |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
Market Overview |
China Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
EUROPE |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
A Mature yet Growing Market |
EXHIBIT: Number of New Cancer Cases in Europe: 2012, 2018, and 2025 |
EXHIBIT: Distribution of New Cancer Cases by Type in Europe: 2018 |
Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Molecular Cytogenetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
FRANCE |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
GERMANY |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
Market Overview |
UK Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Market Overview |
Factors Driving Demand for Laboratory Technologies in Asia-Pacific |
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Molecular Cytogenetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
AUSTRALIA |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
Australia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
INDIA |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
Indian Microarray Market |
India Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
LATIN AMERICA |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Molecular Cytogenetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
ARGENTINA |
Argentina Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Argentina Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Argentina Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Argentina Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
BRAZIL |
Brazil Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Brazil Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Brazil Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Brazil Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
MEXICO |
Mexico Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Mexico Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Mexico Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Mexico Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF LATIN AMERICA |
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Rest of Latin America Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
MIDDLE EAST |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Molecular Cytogenetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
IRAN |
Iran Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Iran Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Iran Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Iran Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
ISRAEL |
Israel Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Israel Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Israel Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Israel Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
SAUDI ARABIA |
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Saudi Arabia Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
UNITED ARAB EMIRATES |
UAE Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
UAE Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
UAE Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
UAE Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF MIDDLE EAST |
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Rest of Middle East Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
AFRICA |
Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
Africa Recent Past, Current & Future Analysis for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Molecular Cytogenetics by Component - Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Molecular Cytogenetics by Component - Percentage Breakdown of Value Revenues for Consumables, Instruments and Software & Services for the Years 2012, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Molecular Cytogenetics by Technique - CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Molecular Cytogenetics by Technique - Percentage Breakdown of Value Revenues for CGH, FISH, Immunohistochemistry, Karyotyping and Other Techniques for the Years 2012, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Molecular Cytogenetics by Application - Genetic Disorders, Cancer, Personalized Medicine and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Molecular Cytogenetics by Application - Percentage Breakdown of Value Revenues for Genetic Disorders, Cancer, Personalized Medicine and Other Applications for the Years 2012, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Molecular Cytogenetics by End-Use - Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Molecular Cytogenetics by End-Use - Percentage Breakdown of Value Revenues for Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes and Other End-Uses for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 44 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com